Skip to main content
SpringerLink
Log in

Biomarkers, Electrocardiography, and Echocardiography

  • Chapter
  • First Online:
COVID-19 Critical and Intensive Care Medicine Essentials

  • 433 Accesses

Abstract

Similarly to severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), [1] coronavirus disease 2019 (COVID-19) is associated with a significant burden of cardiovascular (CV) complications ranging from isolated myocardial injury (elevation of cardiac troponin [cTn]) to acute heart failure, cardiac arrhythmias, venous and pulmonary thromboembolism, arterial thrombotic events, acute coronary syndromes, myocarditis, cardiogenic shock, and cardiac arrest [2, 3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016;49:129–33.

    Article  Google Scholar 

  2. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and cardiovascular disease. Circulation. 2020;141(20):1648–55.

    Article  CAS  Google Scholar 

  3. Pellicori P, Doolub G, Wong CM, et al. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database Syst Rev. 2021;3(3):CD013879.

    PubMed  Google Scholar 

  4. The European Society for Cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance.

  5. Giustino G, Croft LB, Stefanini GG, et al. Characterization of myocardial injury in patients with COVID-19. J Am Coll Cardiol. 2020;76(18):2043–55.

    Article  CAS  Google Scholar 

  6. Parohan M, Yaghoubi S, Seraji A. Cardiac injury is associated with severe outcome and death in patients with coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Eur Heart J Acute Cardiovasc Care. 2020;9(6):665–77.

    Article  Google Scholar 

  7. Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802–10.

    Article  Google Scholar 

  8. Lombardi CM, Carubelli V, Iorio A, et al. Association of troponin levels with mortality in Italian patients hospitalized with coronavirus disease 2019: results of a multicenter study. JAMA Cardiol. 2020;5(11):1274–80.

    Article  Google Scholar 

  9. Lai CC, Sung MI, Ho CH, et al. The prognostic value of N-terminal proB-type natriuretic peptide in patients with acute respiratory distress syndrome. Sci Rep. 2017;7:44784.

    Article  CAS  Google Scholar 

  10. Mitaka C, Hirata Y, Nagura T, et al. Increased plasma concentrations of brain natriuretic peptide in patients with acute lung injury. J Crit Care. 1997;12:66–71.

    Article  CAS  Google Scholar 

  11. Sorrentino S, Cacia M, Leo I, et al. B-type natriuretic peptide as biomarker of COVID-19 disease severity—a meta-analysis. J Clin Med. 2020;9(9):2957.

    Article  CAS  Google Scholar 

  12. Gao L, Jiang D, Wen XS, et al. Prognostic value of NT-proBNP in patients with severe COVID-19. Respir Res. 2020;21(1):83.

    Article  CAS  Google Scholar 

  13. Halaby R, Popma CJ, Cohen A, et al. d-Dimer elevation and adverse outcomes. J Thromb Thrombolysis. 2015;39(1):55–9.

    Article  Google Scholar 

  14. Rostami M, Mansouritorghabeh H. d-Dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol. 2020;13(11):1265–75.

    Article  CAS  Google Scholar 

  15. Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.

    Article  CAS  Google Scholar 

  16. Taylor FB Jr, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327–30.

    Article  CAS  Google Scholar 

  17. Bertini M, Ferrari R, Guardigli G, et al. Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement. Europace. 2020;22(12):1848–54.

    Article  Google Scholar 

  18. Haseeb S, Gul EE, Çinier G, et al. Value of electrocardiography in coronavirus disease 2019 (COVID-19). J Electrocardiol. 2020;62:39–45.

    Article  Google Scholar 

  19. Poterucha TJ, Elias P, Jain SS, et al. Admission cardiac diagnostic testing with electrocardiography and troponin measurement prognosticates increased 30-day mortality in COVID-19. J Am Heart Assoc. 2021;10(1):e018476.

    Article  CAS  Google Scholar 

  20. Elias P, Poterucha TJ, Jain SS, et al. The prognostic value of electrocardiogram at presentation to emergency department in patients with COVID-19. Mayo Clin Proc. 2020;95(10):2099–109.

    Article  CAS  Google Scholar 

  21. Bhatla A, Mayer MM, Adusumalli S, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020;17(9):1439–44.

    Article  Google Scholar 

  22. Skulstad H, Cosyns B, Popescu BA, et al. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. Eur Heart J Cardiovasc Imaging. 2020;21(6):592–8.

    Article  Google Scholar 

  23. Kirkpatrick JN, Mitchell C, Taub C, Kort S, Hung J, Swaminathan M. ASE statement on protection of patients and echocardiography service providers during the 2019 novel coronavirus outbreak: endorsed by the American College of Cardiology. J Am Soc Echocardiogr. 2020;33(6):648–53.

    Article  Google Scholar 

  24. Szekely Y, Lichter Y, Taieb P, et al. Spectrum of cardiac manifestations in COVID-19: a systematic echocardiographic study. Circulation. 2020;142(4):342–53.

    Article  CAS  Google Scholar 

  25. Li Y, Li H, Li M, et al. The prevalence, risk factors and outcome of cardiac dysfunction in hospitalized patients with COVID-19. Intensive Care Med. 2020;46(11):2096–8.

    Article  CAS  Google Scholar 

  26. Gilad V, De Marzo V, Guglielmi G, et al. Cardiac point-of-care ultrasound in hospitalized coronavirus disease-2019 patients: findings and association with outcome. J Cardiovasc Med. 2021;23(1):e3–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiology Unit, Cardiothoracic and Vascular Department, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

    Vered Gil Ad

  2. Cardiovascular Disease, Department of Internal Medicine and Specialties (Di.M.I.), University of Genova, Genova, Italy

    Andrea Carlo Merlo

Authors
  1. Vered Gil Ad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea Carlo Merlo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Anesthesia and Critical Care Unit, Ospedale San Martino, Genova, Italy

    Denise Battaglini

  2. Anesthesia and Critical Care, Ospedale San Martino, Genoa, Italy

    Paolo Pelosi

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gil Ad, V., Merlo, A.C. (2022). Biomarkers, Electrocardiography, and Echocardiography. In: Battaglini, D., Pelosi, P. (eds) COVID-19 Critical and Intensive Care Medicine Essentials. Springer, Cham. https://doi.org/10.1007/978-3-030-94992-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-94992-1_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-94991-4

  • Online ISBN: 978-3-030-94992-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation